SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 183 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $395,581 | -76.1% | 1,073,491 | -72.1% | 0.00% | -100.0% |
Q3 2022 | $1,654,000 | -73.7% | 3,844,988 | -52.2% | 0.00% | -71.4% |
Q2 2022 | $6,281,000 | -37.9% | 8,051,858 | +2.6% | 0.01% | -22.2% |
Q1 2022 | $10,121,000 | +823.4% | 7,845,726 | +809.5% | 0.01% | +800.0% |
Q4 2021 | $1,096,000 | +99.3% | 862,637 | +241.5% | 0.00% | – |
Q3 2021 | $550,000 | -74.4% | 252,625 | -55.9% | 0.00% | -100.0% |
Q2 2021 | $2,151,000 | +26.0% | 573,398 | +9.5% | 0.00% | 0.0% |
Q1 2021 | $1,707,000 | -55.8% | 523,839 | -53.7% | 0.00% | -33.3% |
Q4 2020 | $3,860,000 | +0.6% | 1,131,840 | +20.3% | 0.00% | -25.0% |
Q3 2020 | $3,838,000 | -27.1% | 940,784 | -39.6% | 0.00% | -33.3% |
Q2 2020 | $5,266,000 | +236.9% | 1,558,075 | +132.3% | 0.01% | +200.0% |
Q1 2020 | $1,563,000 | +89.0% | 670,606 | +195.0% | 0.00% | +100.0% |
Q4 2019 | $827,000 | +21.8% | 227,308 | +462.3% | 0.00% | 0.0% |
Q3 2018 | $679,000 | -92.4% | 40,426 | -90.6% | 0.00% | -91.7% |
Q2 2018 | $8,968,000 | -59.3% | 427,847 | -68.8% | 0.01% | -60.0% |
Q1 2018 | $22,054,000 | -41.5% | 1,370,617 | -31.1% | 0.03% | -42.3% |
Q4 2017 | $37,682,000 | -6.0% | 1,988,477 | -30.2% | 0.05% | -16.1% |
Q3 2017 | $40,088,000 | +117.1% | 2,849,168 | +14.9% | 0.06% | +100.0% |
Q2 2017 | $18,467,000 | +19.6% | 2,478,787 | +4.4% | 0.03% | +14.8% |
Q1 2017 | $15,437,000 | +65.2% | 2,374,848 | +12.6% | 0.03% | +68.8% |
Q4 2016 | $9,347,000 | -0.9% | 2,109,895 | +4.5% | 0.02% | -5.9% |
Q3 2016 | $9,431,000 | -31.9% | 2,019,370 | -4.2% | 0.02% | -34.6% |
Q2 2016 | $13,853,000 | +75.8% | 2,108,614 | +70.2% | 0.03% | +85.7% |
Q1 2016 | $7,879,000 | +32.4% | 1,238,760 | +25.5% | 0.01% | +55.6% |
Q4 2015 | $5,952,000 | +95.0% | 987,110 | +93.3% | 0.01% | +125.0% |
Q3 2015 | $3,053,000 | +825.2% | 510,634 | +959.2% | 0.00% | – |
Q2 2015 | $330,000 | -32.0% | 48,209 | -39.7% | 0.00% | -100.0% |
Q1 2015 | $485,000 | -55.3% | 79,891 | -40.2% | 0.00% | 0.0% |
Q2 2014 | $1,086,000 | +570.4% | 133,573 | +545.4% | 0.00% | – |
Q1 2014 | $162,000 | -93.6% | 20,697 | -92.8% | 0.00% | -100.0% |
Q4 2013 | $2,532,000 | -77.3% | 286,096 | -78.5% | 0.00% | -83.3% |
Q3 2013 | $11,142,000 | +24.2% | 1,328,061 | +10.5% | 0.02% | +5.9% |
Q2 2013 | $8,969,000 | – | 1,202,281 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
CM Management, LLC | 600,000 | $468,000 | 0.50% |
ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
Ergoteles LLC | 744,275 | $581,000 | 0.02% |
Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |